Apolipoprotein C-III: going back to the future for a lipid drug target
- PMID: 23704213
- DOI: 10.1161/CIRCRESAHA.113.301464
Apolipoprotein C-III: going back to the future for a lipid drug target
Keywords: antisense oligonucleotides; apolipoprotein C-III; triglyceride; very low-density lipoprotein.
Comment on
-
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.Circ Res. 2013 May 24;112(11):1479-90. doi: 10.1161/CIRCRESAHA.111.300367. Epub 2013 Mar 29. Circ Res. 2013. PMID: 23542898 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical